Market Waking Up to Abbvie's (ABBV) Strong Pipeline - Jefferies

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/21/2026

1. SPCX
2. NVDA
3. NFLX
4. ISRG
5. META
6. TSLA
7. RTX
8. SMCI
9. S
10. COF

Go back to Market Waking Up to Abbvie's (ABBV) Strong Pipeline - Jefferies

Goldman Sachs Raises PT on Abbvie (ABBV) to $52

April 29, 2013 10:45 AM EDT

Goldman Sachs today maintained a Buy rating on Abbvie (NYSE: ABBV) and raised its price target to $52.00 (from $45.00). Analyst Jami Rubin said he had greater confidence in Humira growth and in Abbvie's pipeline.

"We estimate that in a best case... More

Abbvie, Inc. (ABBV) Tops Q1 EPS by 1c; Reaffirms Outlook

April 26, 2013 7:52 AM EDT

(Updated - April 26, 2013 7:59 AM EDT)

AbbVie (NYSE: ABBV) reported Q1 EPS of $0.68, $0.01 better than the analyst estimate of $0.67. Revenue for the quarter came in at $4.33 billion, versus $4.17 billion reported last year.

On an operational basis, sales increased 5.1 percent, excluding a 1.4 percent unfavorable impact from foreign exchange rate... More